Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study
Background Post-COVID-19 condition has recently been defined as new or persistent common COVID-19 symptoms occurring three months after disease onset. The pathology of the disease is unclear, but immune and vascular factors seem to play a significant role. The incidence, severity, and implications o...
| Autores: | , , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Fecha de publicación: | 2024 |
| País: | España |
| Recursos: | Universidad Complutense de Madrid (UCM) |
| Repositorio: | Docta Complutense |
| Idioma: | inglés |
| OAI Identifier: | oai:docta.ucm.es:20.500.14352/115083 |
| Acesso em linha: | https://hdl.handle.net/20.500.14352/115083 |
| Access Level: | acceso abierto |
| Palavra-chave: | 616.98:578.834 578.834:616.98 Post-COVID-19 Long COVID Pregnancy Postpartum Perinatal COVID-19 Obstetrics Ciencias Biomédicas 32 Ciencias Médicas |
| id |
ES_7bcfd319a604e0e23df435abc847a3bb |
|---|---|
| oai_identifier_str |
oai:docta.ucm.es:20.500.14352/115083 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study |
| title |
Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study |
| spellingShingle |
Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study Muñoz-Chápuli Gutiérrez, Mar 616.98:578.834 578.834:616.98 Post-COVID-19 Long COVID Pregnancy Postpartum Perinatal COVID-19 Obstetrics Ciencias Biomédicas 32 Ciencias Médicas |
| title_short |
Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study |
| title_full |
Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study |
| title_fullStr |
Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study |
| title_full_unstemmed |
Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study |
| title_sort |
Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study |
| dc.creator.none.fl_str_mv |
Muñoz-Chápuli Gutiérrez, Mar Sáez Prat, Ainoa Durán Vila, Ana Bernal Claverol, Mireia Payá Martínez, Pilar Pintado Recarte, María Del Pilar Viñuela Benéitez, Mamen Ausín García, Cristina Cervilla Muñoz, Eva Navarro, Marisa González Navarro, Pablo Álvarez Mon, Melchor Ortega, Miguel A. León Luis, Juan Antonio |
| author |
Muñoz-Chápuli Gutiérrez, Mar |
| author_facet |
Muñoz-Chápuli Gutiérrez, Mar Sáez Prat, Ainoa Durán Vila, Ana Bernal Claverol, Mireia Payá Martínez, Pilar Pintado Recarte, María Del Pilar Viñuela Benéitez, Mamen Ausín García, Cristina Cervilla Muñoz, Eva Navarro, Marisa González Navarro, Pablo Álvarez Mon, Melchor Ortega, Miguel A. León Luis, Juan Antonio |
| author_role |
author |
| author2 |
Sáez Prat, Ainoa Durán Vila, Ana Bernal Claverol, Mireia Payá Martínez, Pilar Pintado Recarte, María Del Pilar Viñuela Benéitez, Mamen Ausín García, Cristina Cervilla Muñoz, Eva Navarro, Marisa González Navarro, Pablo Álvarez Mon, Melchor Ortega, Miguel A. León Luis, Juan Antonio |
| author2_role |
author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Universidad Complutense de Madrid |
| dc.subject.none.fl_str_mv |
616.98:578.834 578.834:616.98 Post-COVID-19 Long COVID Pregnancy Postpartum Perinatal COVID-19 Obstetrics Ciencias Biomédicas 32 Ciencias Médicas |
| topic |
616.98:578.834 578.834:616.98 Post-COVID-19 Long COVID Pregnancy Postpartum Perinatal COVID-19 Obstetrics Ciencias Biomédicas 32 Ciencias Médicas |
| description |
Background Post-COVID-19 condition has recently been defined as new or persistent common COVID-19 symptoms occurring three months after disease onset. The pathology of the disease is unclear, but immune and vascular factors seem to play a significant role. The incidence, severity, and implications of the disease after COVID-19 infection in pregnancy have not been established. We aimed to study the incidence and main risk factors for post-COVID-19 condition in an obstetric population and their implications for maternal and perinatal morbimortality. Methods This is a prospective observational cohort study undertaken including women during pregnancy or at admission for labour with acute COVID-19 infection from March 9th, 2020 to June 11th, 2022. The inclusion criteria were confirmed acute COVID-19 infection during the recruitment period, a lack of significant language barrier and consent for follow-up. Patients were clinically followed-up by telephone via semi structured questionnaires. The exclusion criteria were loss to follow-up, spontaneous miscarriage, and legal termination of pregnancy. Patients were classified into groups according to the severity of symptoms at onset. We included patients from the first six first waves of the pandemic according to national epidemiological data in Spain. We studied the incidence of post-COVID-19 condition and their main demographic, clinical and obstetric risk factors. Findings A total of 409 pregnant women were recruited at acute diagnosis, and 286 were followed-up. The mean time to follow-up was 92 weeks (standard deviation ± 28 weeks; median 100 weeks (Interquartile range: 76; 112)). A total of 140 patients had at least one post-COVID-19 symptom at least three months after acute infection. Neurological (60%) and cutaneous (55%) manifestations were the most frequent findings. The following profiles were identified as presenting a higher risk of post-COVID-19 condition: migrant women born in countries with lower Human Development Index; multiparous women; women with COVID-19 during pregnancy, mainly during the first and third trimesters, and in the first and second waves of the pandemic; women who had a higher number of symptoms; women who had a higher incidence of moderate and severe symptoms; women who required hospitalisation due to COVID-19 complications; and women who were not vaccinated before disease onset. We did not find any significant difference in perinatal results, such as gestational week at delivery, birthweight, the need for neonatal care or 5-min Apgar score, and newborns benefited from a high rate of breastfeeding at discharge. Women who were infected during successive waves of the pandemic had a significant and constant decrease in the risk of post-COVID-19 condition comparing to estimated risk in the first wave (OR: 0.70; 95% CI: 0.62, 0.92). Symptoms tended to resolve over time heterogeneously. Symptoms of myalgia and arthralgia took longer to resolve (mean of 60 weeks and 54 weeks, respectively). In a small but significant proportion of patients, neurological and psycho-emotional symptoms tended to become chronic after 90 weeks. Interpretation At least 34.2% of obstetric patients from our cohort with acute COVID-19 infection presented post-COVID-19 condition symptoms. Demographic and acute disease characteristics as well as specific pregnancy-related risk factors were identified. This is the first study to assess post-COVID-19 condition in pregnant women. Further analysis on the biological pathophysiology of post-COVID-19 is needed to explain the characteristics of the disease. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 2024-01-01 2024 2024-01-01 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/20.500.14352/115083 |
| url |
https://hdl.handle.net/20.500.14352/115083 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
reponame:Docta Complutense instname:Universidad Complutense de Madrid (UCM) |
| instname_str |
Universidad Complutense de Madrid (UCM) |
| reponame_str |
Docta Complutense |
| collection |
Docta Complutense |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869411543130570752 |
| spelling |
Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective studyMuñoz-Chápuli Gutiérrez, MarSáez Prat, AinoaDurán Vila, AnaBernal Claverol, MireiaPayá Martínez, PilarPintado Recarte, María Del PilarViñuela Benéitez, MamenAusín García, CristinaCervilla Muñoz, EvaNavarro, MarisaGonzález Navarro, PabloÁlvarez Mon, MelchorOrtega, Miguel A.León Luis, Juan Antonio616.98:578.834578.834:616.98Post-COVID-19Long COVIDPregnancyPostpartumPerinatalCOVID-19ObstetricsCiencias Biomédicas32 Ciencias MédicasBackground Post-COVID-19 condition has recently been defined as new or persistent common COVID-19 symptoms occurring three months after disease onset. The pathology of the disease is unclear, but immune and vascular factors seem to play a significant role. The incidence, severity, and implications of the disease after COVID-19 infection in pregnancy have not been established. We aimed to study the incidence and main risk factors for post-COVID-19 condition in an obstetric population and their implications for maternal and perinatal morbimortality. Methods This is a prospective observational cohort study undertaken including women during pregnancy or at admission for labour with acute COVID-19 infection from March 9th, 2020 to June 11th, 2022. The inclusion criteria were confirmed acute COVID-19 infection during the recruitment period, a lack of significant language barrier and consent for follow-up. Patients were clinically followed-up by telephone via semi structured questionnaires. The exclusion criteria were loss to follow-up, spontaneous miscarriage, and legal termination of pregnancy. Patients were classified into groups according to the severity of symptoms at onset. We included patients from the first six first waves of the pandemic according to national epidemiological data in Spain. We studied the incidence of post-COVID-19 condition and their main demographic, clinical and obstetric risk factors. Findings A total of 409 pregnant women were recruited at acute diagnosis, and 286 were followed-up. The mean time to follow-up was 92 weeks (standard deviation ± 28 weeks; median 100 weeks (Interquartile range: 76; 112)). A total of 140 patients had at least one post-COVID-19 symptom at least three months after acute infection. Neurological (60%) and cutaneous (55%) manifestations were the most frequent findings. The following profiles were identified as presenting a higher risk of post-COVID-19 condition: migrant women born in countries with lower Human Development Index; multiparous women; women with COVID-19 during pregnancy, mainly during the first and third trimesters, and in the first and second waves of the pandemic; women who had a higher number of symptoms; women who had a higher incidence of moderate and severe symptoms; women who required hospitalisation due to COVID-19 complications; and women who were not vaccinated before disease onset. We did not find any significant difference in perinatal results, such as gestational week at delivery, birthweight, the need for neonatal care or 5-min Apgar score, and newborns benefited from a high rate of breastfeeding at discharge. Women who were infected during successive waves of the pandemic had a significant and constant decrease in the risk of post-COVID-19 condition comparing to estimated risk in the first wave (OR: 0.70; 95% CI: 0.62, 0.92). Symptoms tended to resolve over time heterogeneously. Symptoms of myalgia and arthralgia took longer to resolve (mean of 60 weeks and 54 weeks, respectively). In a small but significant proportion of patients, neurological and psycho-emotional symptoms tended to become chronic after 90 weeks. Interpretation At least 34.2% of obstetric patients from our cohort with acute COVID-19 infection presented post-COVID-19 condition symptoms. Demographic and acute disease characteristics as well as specific pregnancy-related risk factors were identified. This is the first study to assess post-COVID-19 condition in pregnant women. Further analysis on the biological pathophysiology of post-COVID-19 is needed to explain the characteristics of the disease.ElsevierUniversidad Complutense de Madrid20242024-01-0120242024-01-01journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/115083reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/1150832026-06-02T12:44:21Z |
| score |
15,81155 |